Filing metadata

Accession number
0000921895-22-002054
Form type
Form 3
Filer
Oruka Therapeutics, Inc.
CIK
CIK 907654
Filed
Jun 21, 2022
Reporting period
Jun 15, 2022
Description
Initial ownership

Explore SEC Filings Hub